EffRx Pharmaceuticals, a commercial-stage pharmaceutical company, focuses on late-stage development and commercialization of prescription medications for orphan indications. The business model provides superior clinical and commercial value propositions for physicians, payers and patients. EffRx pro-actively seeks European in-licensing opportunities in niche therapeutic areas, with a primary interest for rare diseases.
We offer a single entry point for our partners with orphan portfolios in CEE, LATAM, MENAT, Russia and CIS, and Switzerland.
Together we can achieve more.
With deep understanding of local healthcare systems, we can support our partners to expand their business throughout the complex WODA regions.